Followers | 5 |
Posts | 108 |
Boards Moderated | 0 |
Alias Born | 09/25/2014 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Following the trend of the broader pharmaceutical world, Johnson & Johnson’s medtech division is interested and ready for partnering out – pushing a decentralized business model that focuses heavily on external collaboration.
“We have the humility to understand that we don’t own all the information or knowledge on medical technology,” Martin Fitchet, global head of R&D for J&J Medical Devices, said in an interview at this week’s AdvaMed 2015 conference in San Diego. “There’s a big world out there. Academia. Startups. Other companies. Government. All working on technologies that we’d love to partner with, and add our expertise.”
Indeed, despite a pattern of stagnant funding in the medical device industry, the medtech behemoth is optimistic and looking to branch out – pursuing early stage technologies. J&J already has a well-established innovations arm and a venture capital team – and it’s looking to expand..."
http://medcitynews.com/2015/10/jjs-medtech-arm-partnering-out-pushing-innovation-agenda/
Check this out scalpel. Fresh off the press:
"In March, Google announced a partnership with Ethicon, owned by Johnson & Johnson, to develop a surgical robot. Wired reported that Ethicon will build it, while Google will focus on creating algorithms that analyze camera images to help surgeons improve. Titan Medical of Canada is in the second phase of developing the SPORT (Single Port Orifice Robotic Technology), a robot similar to the da Vinci. Expected to be market ready by mid-2017, it should come in well below competitors at a cost of approximately $600,000."
http://www.sanjoseinside.com/2015/08/27/advances-in-robotic-surgeries-lead-to-higher-demand-despite-marketing-regulation-concerns/
Not a pumper, been in and out for years. Now, I got my feet cemented.
Cut me some slack:
http://investorshub.advfn.com/Boards/read_msg.aspx?message_id=114720647
FYI. Not done with the buying—scaling in.
$TITXF is a hidden gem.
Thanks for the alert popeyemag!!
Yes, I received this pump publication couple weeks ago. I posted it on my twitter page. Take note of the fine print disclosure on the bottom of page 27. I'm currently looking at it now—wow, what a mess.
The pump is still in it's early stages, I think this can really get going once all the direct mail goes out and sucks in all the retail buyers. Be ready for the ride, if and when it happens. All we need is for Kathy to do pump commercials so they can air during cnbc and fox business!
In the end, all pumps and dumps have the same ending.
Good luck popeyemag
Hey goldrusher, A 5.8 million dollar pump is pretty insane — some deep pockets going in....Kathy doesn't want it to drop down past $3.
I think this baby can run if it can suck enough people into this Pump&Dump. Double digits would be ideal, but the volume is still anemic — Kathy needs to do a better job.
It's insane to think how much money is now being spent to pump this stock. Unbelievable. Great job Kathy!
I have several twitter post that I'll do this weekend on $NUGN. Watch for when I disclose the cash spent on marketing. $NUGN being pushed in a major way, still in early innings.
https://twitter.com/jeeztrades
$NUGN Kathy Ireland and Associates are paying a lot of money for this big campaign rollout. Will disclose the dollar amount invested in this pump. It's insane.
$NUGN Currently doing a twitter feed on this stock https://twitter.com/jeeztrades
There's some important information that I plan to disclose.
Knew this was coming...based on their balance sheet and burn rate. The warrants are now worth peanuts! As a result, you dilute to reach commercialization. Already under $1 today — some bleeding going on.
$TITXF is the dog in my portfolio, https://twitter.com/jeeztrades. Will look to add when this starts to consolidate. I wonder what Sherry Bertner is up to?
Just like stocks, I'm keeping this board on my radar. Great job Kaboom!!!
https://twitter.com/jeeztrades
Good question StockScout1.
Flux Carbon Starter Fund filled a SC 13D form regarding $PVSP. Per Flux Carbon Starter Fund Llc’s filling, the filler reported increased stake in the company by 78.36% to 1,000,000,000 shares. Flux Carbon Starter Fund Llc now owns 25.5% of the company.
Item 4. Purpose of Transaction
At the time of their acquisition of the Company’s shares, as set forth in Item 3, neither Flux Carbon Corporation nor Kevin Kreisler had any plan or proposal which relates to or would result in any of the actions or transactions described in paragraphs (a) through (j) of the instructions to Item 4 of Schedule 13D.
FYI!!!!!!!
Form 13D is SEC filing that must be submitted within 10 days, by anyone who acquires beneficial ownership of more than 5% of any publicly traded securities. A filer must promptly update its 13D filing in case of acquisition or disposition of 1% or more of the securities that are the subject of the filing. These filings may be a precursor to hostile takeovers, company breakups, and other “change of control” events.
You missed the point. The CEO has a shady past.
He's currently the Chairman, Chief Exec. Officer, Chief Financial Officer, Principal Accounting Officer, Treasurer and Sec. Is he the janitor too? It's just getting better...I found more sec filings.
This will probably run more, but I'm putting this out there for people to be on their toes.
Don't be afraid to take profits.
Another important read:
"Paul Riss’s deal with Magna in July 2011 was typical. The New York entrepreneur’s company, Pervasip, was developing a communications app to compete with Skype, but it was down to its last $100,000, barely enough to last a month at the rate the company was losing money. When Magna’s “Michael Goldberg” called offering cash, he didn’t even ask to look at the app, Riss says. “All they care about is the liquidity of the stock,” he says. “They want to see how many dollars are trading a month.”
On the surface, the $75,000 loan Magna offered seemed all right. It was in the form of an “8 percent convertible promissory note,” meaning it asked for an 8 percent return and gave Sason the right to convert it into stock. The fine print explained that if Pervasip didn’t pay back the money within six months, the lender could convert at a 45 percent discount to the market price. So, no matter where Pervasip’s stock was trading, the company had to give Magna shares that were worth more than $136,000—an 82 percent return in just six months. Essentially, Magna locked in a fixed return.
The lower the shares went, the more Pervasip had to give up so Magna could get its money. The only risk Magna took is that no one would buy Pervasip’s stock at any price. “Unfortunately, that’s about the only money available,” Riss says.
Pervasip didn’t repay, and gave the discounted shares to Magna in January 2012. Riss says he doesn’t have records that show just how much Magna made. After bouncing up to 3¢ for a bit, Pervasip now trades for nine-thousandths of a penny. Riss says he still gets calls from lenders like Magna offering more money.
An analysis of 80 public filings shows that a company that does a deal with Magna sees its shares plummet 55 percent over the next year, on average. Most never recover and wind up trading for thousandths of a penny or less. Sason says that’s not Magna’s fault."
http://www.bloomberg.com/news/articles/2015-03-12/josh-sason-made-millions-from-penny-stock-financing
That was filed on November 30, 2014. I'm sure nothing has changed.
This is the dagger:
"As of November 30, 2014, our accumulated deficit was $51,764,832"
cashstrapped, imagine owning a 51 million dollar home, and you can't pay your monthly mortgage on it? Talk about being cash strapped!
They will continue to dilute the shares. MANY shady people buy publicly listed shell companies and rename them. There's less underwriting, and there's no need for an IPO. A shell can be completed in 1 to 2 month versus 6 to 12 months of doing a public offering.
http://markets.on.nytimes.com/research/stocks/fundamentals/drawFiling.asp?docKey=136-000101738615000094-4JP062317C8USQQMLF2NNHO3L5&docFormat=HTM&formType=10-K
Time for the reality check. The SEC doesn't lie. I provided the URL link below for validation. This has a ton of valid information — please read through when you get a chance. Its a real eye opener. I run across these all the time.
I posted a few key lines from the 10-K filed with the SEC:
Description of Business
"Pervasip Corp. (“Pervasip”, or the “Company”) is an application-based Internet company, and primarily provides low-cost telephone services, connecting people through cloud-connected devices worldwide. Most of the Company’s revenues are derived from customers in the United States that use the Company’s applications to access Internet-based telephone services. "
"We maintain a corporate website with the address http://www.pervasip.com. "
"In fiscal 2014 and 2013, we had one customer that accounted for 27% and 36% of our revenues, respectively. We also had a customer that accounted for 24% of our revenues in fiscal 2014. These two customers were part of the assets we sold on September 30, 2014. At November 30, 2013, one customer, Global Connect LLC, constituted 48% of our accounts receivable."
"We have a history of significant, recurring losses from operations, and we may continue to incur significant losses for the foreseeable future. We reported net operating losses of $850,576 in fiscal 2014 and $1,240,476 in fiscal 2013. As of November 30, 2014, our accumulated deficit was $51,764,832."
We need additional capital to continue our operations.
"We sustained significant operating losses in the past 10 years as we have built our cloud-based technology and business. It has used all our cash and forced us to raise capital to pay our bills. As of November 30, 2014, we had negative working capital of approximately $9.4 million and negative stockholders’ equity of approximately $9.4 million. We believe it is probable that we will continue to experience losses and increased negative working capital and negative stockholders’ equity in the near future, and that we will not be able to achieve positive cash flow before we require additional capital."
"As of April 24, 2015 we had 2 full-time and 3 part-time employees. We plan to operate with a small number of employees until our revenues increase further or until we are able to attract additional financing that has money earmarked for sales and marketing expense."
"Our accounts payable and accrued expenses totaled $1,966,224 at November 30, 2014. Among the creditors to whom we owe money are enterprises that provide important support for our business operations. If we continue to be unable to pay those creditors on a current basis, they may become unwilling to provide services to us. Given our poor record of paying our creditors, replacement vendors could demand deposits, which we might be unable to pay. Some combination of these events, if they occurred, could cause a termination of our business operations."
There's a lot more I didn't post, but you get the idea. Good luck.
http://markets.on.nytimes.com/research/stocks/fundamentals/drawFiling.asp?docKey=136-000101738615000094-4JP062317C8USQQMLF2NNHO3L5&docFormat=HTM&formType=10-K
That's crazy. Shorting this... would be like you playing Russian roulette.
Being honest, no need to be hostile. You need an exit strategy with these type of pink sheet plays. The WIDE price swings come and go, so you need to be on your toes. Good luck Bjones2.
Case in point. Take a look at TICKER: OWOO
This baby ran big, similar action as PVSP. Bottom line...take profits when you got them.
FYI:
PVSP share structure:
Shares Outstanding: 4.70B
Float: 3.14B
http://finance.yahoo.com/q/ks?s=PVSP+Key+Statistics
FYI:
Level 2 showing 1million plus on the Ask.
I just called. Trust me, I was looking to buy for a quick scalp. But it looks very shady. Typical pump and dump.
I've seen strip mall address used in the past, but a church location! This makes for a perfect story.
Take a look at the bottom footers on the trinity site — what a mess. Looks like the church is in the business of selling drugs.
Trinity Lutheran Church of White Plains
430 North Street | White Plains, New York 10605
info@tlcwp.org
(914) 761-6038
Office Hours: Mondays, Wednesdays & Thursdays 9am-12pm dapoxetine for sale online generic drug cialis purchasing cialis from canada enquiry buy diflucan uk
http://www.trinitylutheranchurchwhiteplains.org
kamagra offer genuine viagra overnight viagra products online anonymous female pink viagra online Trinity Lutheran Church of White Plains
430 North Street | White Plains, New York 10605
info@tlcwp.org
(914) 761-6038
Office Hours: Mondays, Wednesdays & Thursdays 9am-12pm doxycycline generic price philippines home generika apotheke finpecia blog abilify no prescription needed synthroid master card
http://www.trinitylutheranchurchwhiteplains.org/history
Confirm for yourself, its just a phone call away. I did, it will save you a big headache.
Take care, and happy trading.
Call their number now to confirm.
30 North Street
White Plains, NY 10605
United States - Map
Phone: 914-750-9339
http://www.trinitylutheranchurchwhiteplains.org/saturday-academy
Trinity Lutheran Church of White Plains
430 North Street | White Plains, New York 10605
info@tlcwp.org
(914) 761-6038
I just called their number. They are indeed located in White Plains. Call for yourself.
Pervasip Corp.
430 North Street
White Plains, NY 10605
United States - Map
Phone: 914-750-9339
http://finance.yahoo.com/q/pr?s=PVSP+Profile
Where is the web site? How many employees do they have listed? Just several red flags.
$PVSP Marijuana pump & dump. Address is associated to a Trinity Church!
http://finance.yahoo.com/q/pr?s=PVSP+Profile
http://www.trinitylutheranchurchwhiteplains.org/saturday-academy
Exactly, a dilution would drive the share price further downward.
If $TITXF breaks the 1.20-ish support, expect to see the 1 dollar mark. The Greece debt default issue is not helping the situation either.
Agree with you on their IR/PR strategy.
$TITXF should just allocate that monthly retainer payout to you and the moderators: buccaneer1961, Honeycomb777, cjrick01, investinthefuture, cptjsd, Times Yours. You guys are doing good work by putting the Titan story out there for potential investors. Keep it up!
Cheers,
@JeezTrades
Thanks for your input CUIN2. I'm a bull, but I think the capital at hand is weighing on the share price. Investors want visibility, and right now it's looking a little foggy. The technology is definitely there, but what matters too is the capital.
By the way, the Bertner monthly retainer fee isn't cheap.
@Bobbysixty not trying to rock the boat, but just being a realist. The charts don't lie — they are like X-rays.
I couple technical analysis with fundamentals. Anyhow, If you have read my previous post on $TITXF. As of March 31, 2015, Titan has a current burn rate of 3.6 million per month with only 27.4 million at hand. Understand the dilemma Bobby? Its like trying to pay the mortgage with a dwindling savings account. And you know, dilution and share price don't mix.
Theres also seems to be a lot of "soaking up size" with MMs — being kept down. Market makers are buying/selling shares more than they are showing. Tends to happen in the pink sheet land.
Either way I'm long, but looking to add more. I just need $TITXF to consolidate and find some stability.
Extraordinary technology, thanks for posting this. Looking to add more, but $TITXF has not found a bottom yet. The chart looks ugly, and that 1.20 support is a key area if breaks below.
Anyhow, looking to buy 10k shares. If this hits $1.00, I'll double up, and make it 20k on the buy.
@JeezTrades
CDEL at it again, sitting on 30k at 1.40. Wash trading going on, not good.
An oldie but a goodie on Ethicon:
Technique Spreads
Dr. Fowler presented on his first laparoscopic sigmoid resection at the Society of American Gastrointestinal and Endoscopic Surgeons meeting in April 1991 (Surg Laparosc Endosc 1991;1:183-188).
“I had an overwhelming response from people all over the world,” Dr. Fowler said. “Not many surgeons knew what had been done, and were eager to engage in training programs to learn the procedure.”
As with laparoscopic cholecystectomy, interest in laparoscopic colectomy prompted surgeons to initiate weekend training courses. By November 1991, Dr. Ballantyne had organized courses for U.S. Surgical. Around that time, Ethicon had arranged laparoscopic colectomy workshops, run by Steven Wexner, MD, of Cleveland Clinic, in Weston, Fla. The industry competitors invited many of the same faculty to their courses, and this core group of surgeons soon branched off into U.S. Surgical and Ethicon camps.
Several industry leaders, namely Lee Cohen, head of laparoscopic marketing and technology at U.S. Surgical, in Norwalk, Conn., and Nicholas Valeriani, president of Ethicon Endo-Surgery for many years, supported and pushed the advancement of laparoscopic technology and education. “I often referred to Ms. Cohen as the queen of laparoscopy,” Dr. Ballantyne recalled.
http://www.gastroendonews.com/ViewArticle.aspx?d=In%2Bthe%2BNews&d_id=187&i=September+2014&i_id=1101&a_id=28184
Right, and CDEL on level 2 is a huge shorter, and they account for about 34K on the ASK.
You are on fire man. Talking about due diligence!
Thank you for your input BelizeMe. The return will indeed be great on $TITXF!!!
On thing we should question is their cash on hand, and their monthly burn rate. It's important to know the money on books...For example: Are they going to dilute to fund growth opportunities? Or, dilute to raise funds to service existing debt. Share price and dilution don't mix, like oil and water.
Exactly CUIN2, good take away.
A buy out is almost certain once $TITXF successfully meets their pivotal trial and receives FDA approval. And thats when Sherry L. Bertner can use her strategic investor relations skills to marry
the two.
FYI:
Bertner Advisors will be paid fees of US$20,000 per month for its services, with an annual increase of 5% on such monthly fee. An additional fee of six times the monthly fee shall be paid to Bertner Advisors in the event that a merger, acquisition, consolidation, or other transaction occurs.
Look at the cash burn rate numbers on page 22 on the old version — they didn't include the burn rate on new version.
Do the math: $27.4 mm/$3.6 mm
Cash, cash equivalents and short-term investments : $27.4 million
Current burn rate: $3.6 million per month
This is great — thanks investinthefuture. The $TITXF board is on it! It pays to due diligence. This is definitely PR worthy.
I understand the grassroots approach, but $TITXF needs to view this from an investor's eye. $TITXF needs to get uplisted, that will stimulate buying pressure from the street and yield a much larger buyout offer as a result.
$TITXF main objective should obviously be to hit their projected goal marks, along with issuance of U.S. Patents. But they need to get UPLISTED. Trading on the pinks is not aiding to the share price and that 1.20s support is on my mind. I short stocks, but I would never short this gem. This is a gold mine, we just got to be patient.
I'll tweet the photo. Thanks.
Surgical Robots Market Worth $20 Billion by 2021
DALLAS, May 22, 2015 /PRNewswire/ --
The Surgical Robots Market Shares, Strategies and Forecasts, Worldwide, 2015 to 2021 research report says surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds.
Complete report on surgical robots market spread across 553 pages, talking about 50+ companies and supported with 216 tables and figures is now available at http://www.rnrmarketresearch.com/surgical-robots-market-shares-strategies-and-forecasts-worldwide-2015-to-2021-market-report.html .
This 2015 surgical robots market research says robots bring new automated processes to all segments and worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well-trained group of surgeons able to manage the robots.
Other leading competitors will emerge in the surgical robots market and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. A surgical robot recurring revenue model business model is essentially large one time purchase for a system complimented by replaceable or disposable instruments that cumulatively market a much larger and ongoing market. Vendors make money from the one time sale of a system and recurring revenue from sale of devices used in every operation.
Initially, a vendor sells and installs the surgical system into new customer accounts. Once systems are sold into customer accounts, the vendor generates recurring revenue as our customers use the system to perform surgery. To do surgeries, the customers need to buy and consume instruments and accessory products. Vendors also generate recurring revenue from system service. The ability to deliver such an accurate dose of radiation means that the cancer can be eradicated in patients before the patient is administered a lethal dose of radiation. This represents a cure for cancer once it gets working according to the promise of the systems now in place.
Companies mentioned in this research include Intuitive Surgical, Accuray, Stryker / Mako, Hansen Medical, Medrobotics, Freehand 2010, Accel Spine, Accuray, Aesynt / Health Robotics, Alliance Spine, Alphatec Spine, Amedica, Apollo Spine, Ascendx Spine, AVRA Surgical, Back 2 Basics Spine, Captiva Spine, Centinel Spine, Corindus, Elekta AB, Freehand, Globus Medical, Hansen Medical, Healthcare Robotics Lab, Intuitive Surgical, Johnson and Johnson / DePuy Synthes, K2M, Lanx / EBI Holdings / BioMet /, LDR, Life Spine, Mazor Robotics, Medrobotics, Medtronic, NLT Spine, NuVasive, Otto Bock HealthCare, RTI Biologics / Pioneer Surgical Technology, Precision Spine, Restoration Robotics, SI-BONE 503, Spinal Elements, Spineart, SpineGuard, Spine Frontier, , Spineology, Spine Smith Partners, Spine Surgical Innovations, Spine View, Spine Wave, Stryker / MAKO Surgical, Think Surgical, Titan Medical, TranS1, UC Berkeley, Varian Medical Systems., Vecna Robotics, Victrex plc / Invibio, Vycor, Wenzel Spine, X-spine and Zyga Technology. Order a copy of this research on surgical robots market at http://www.rnrmarketresearch.com/contacts/purchase?rname=384100.
http://www.prnewswire.com/news-releases/surgical-robots-market-worth-20-billion-by-2021-504699701.html
I'm sure Titan has press release worthy information that can clearly move the stock, but instead they continue to be dormant in their PR department. Simple concept — share price will continue to drip with no news releases. The investment community is unaware of TITXF, it's reflected on the share price— plain and simple.